干旱区生态环境知识资源中心(Arid): A Randomized, Double-Blind, Placebo-Controlled Trial of a Selective, Oral Sphingosine 1-Phosphate (S1P) Receptor Modulator, Etrasimod (APD334), in Moderate to Severe Ulcerative Colitis (UC): Results From the OASIS Study

Arid

	A Randomized, Double-Blind, Placebo-Controlled Trial of a Selective, Oral Sphingosine 1-Phosphate (S1P) Receptor Modulator, Etrasimod (APD334), in Moderate to Severe Ulcerative Colitis (UC): Results From the OASIS Study
	Sandborn, William J.1; Peyrin-Biroulet, Laurent 2; Trokan, Luba 3; Zhang, Jinkun 3; Kuhbacher, Tanja 4; Chiorean, Michael 5; Lee, Scott D.6; Vermeire, Severine 7; Yacyshyn, Bruce 8; Naik, Snehal 3; Klassen, Preston 3; Panes, Julian 9
来源期刊	AMERICAN JOURNAL OF GASTROENTEROLOGY
ISSN	0002-9270
EISSN	1572-0241
出版年	2018
卷号	113 页码:S326-S327
类型	Meeting Abstract
语种	英语
国家	USA ; France ; Germany ; Belgium ; Spain
收录类别	SCI-E ; CPCI-S
WOS记录号	WOS:000464611001160
WOS类目	Gastroenterology & Hepatology
WOS研究方向	Gastroenterology & Hepatology
资源类型	期刊论文
条目标识符	http://119.78.100.177/qdio/handle/2XILL650/207490
作者单位	1.Univ Calif San Diego, La Jolla, CA 92093 USA; 2.Univ Lorraine, Univ Hosp Nancy, Nancy, Lorraine, France; 3.Arena Pharmaceut, San Diego, CA USA; 4.Asklepio Westklinikum, Hamburg, Germany; 5.Virginia Mason Med Ctr, Seattle, WA 98101 USA; 6.Univ Washington, Seattle, WA 98195 USA; 7.Univ Hosp Leuven, Leuven, Brussels Hoofds, Belgium; 8.Univ Cincinnati, Cincinnati, OH USA; 9.Hosp Clin Barcelona, IDIBAPS, CIBERehd, Barcelona, Catalonia, Spain
推荐引用方式 GB/T 7714	Sandborn, William J.,Peyrin-Biroulet, Laurent,Trokan, Luba,et al. A Randomized, Double-Blind, Placebo-Controlled Trial of a Selective, Oral Sphingosine 1-Phosphate (S1P) Receptor Modulator, Etrasimod (APD334), in Moderate to Severe Ulcerative Colitis (UC): Results From the OASIS Study[J],2018,113:S326-S327.
APA	Sandborn, William J..,Peyrin-Biroulet, Laurent.,Trokan, Luba.,Zhang, Jinkun.,Kuhbacher, Tanja.,...&Panes, Julian.(2018).A Randomized, Double-Blind, Placebo-Controlled Trial of a Selective, Oral Sphingosine 1-Phosphate (S1P) Receptor Modulator, Etrasimod (APD334), in Moderate to Severe Ulcerative Colitis (UC): Results From the OASIS Study.AMERICAN JOURNAL OF GASTROENTEROLOGY,113,S326-S327.
MLA	Sandborn, William J.,et al."A Randomized, Double-Blind, Placebo-Controlled Trial of a Selective, Oral Sphingosine 1-Phosphate (S1P) Receptor Modulator, Etrasimod (APD334), in Moderate to Severe Ulcerative Colitis (UC): Results From the OASIS Study".AMERICAN JOURNAL OF GASTROENTEROLOGY 113(2018):S326-S327.